Partitioning of bronchopulmonary carcinoids in two different prognostic categories by Ki-67 score

Frontiers in Endocrinology

Volumn 2, Issue AUG, 2010, Pages

  Grimaldi, Franco ^a   Muser, Daniele ^a   Beltrami, Carlo Alberto ^a   Machin, Piernicola ^a   Morelli, Angelo ^a   Pizzolitto, Stefano ^a   Talmassons, Giovanni ^a   Marciello, Francesca ^b   Colao, Annamaria Anita Livia ^b   Monaco, Roberto ^c   Monaco, Guglielmo ^c   Faggiano, Antongiulio ^d  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

Ki 67; Neuroendocrine tumors; Tumor markers

Indexed keywords

EID: 84874149097     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00020     Document Type: Article

References (28)

1. Arbiser, Z. K., Arbiser, J. L., Cohen, C., and Gal, A. A. (2001). Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. Mod. Pathol. 14, 1195-1199.
2. Beasley, M. B., Thunnissen, F. B., Brambilla, E., Hasleton, P., Steele, R., Hammar, S. P., Colby, T. V., Sheppard, M., Shimosato, Y., Koss, M. N., Falk, R., and Travis, W. D. (2000). Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum. Pathol. 31, 1255-1265.
3. Beasley, M. B., Thunnissen, F. B., Hasleton, Ph. S., Barbareschi, M., Pugatch, B, Geisinger, K., Brambilla, E., Gazdar, A., and Travis, W. D. (2004). "Carcinoid tumour, " in Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, edsW.D. Travis, E. Brambilla, H. K. MullerHermelink, and C. C. Harris (Lyon: IARC Press), 59-62.
4. Cooper, W. A., Thourani, V. H., Gal, A. A., Lee, R. B., Mansour, K. A., and Miller, J. I. (2001). The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 119, 14-18.
5. Costes, V., Marty-Ané, C., Picot, M. C., Serre, I., Pujol, J. L., Mary, H., and Baldet, P. (1995). Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI67-labeling study. Hum. Pathol. 26, 740-745.
6. el-Naggar, A. K., Ballance, W., Karim, F. W., Ordóñez, N. G., McLemore, D., Giacco, G. G., and Batsakis, J. G. (1991). Typical and atypical bronchopulmonary carcinoids. A clinicopathologic and flow cytometric study. Am. J. Clin. Pathol. 95, 828-834.
7. Faggiano, A., Mansueto, G., Ferolla, P., Milone, F., del Basso de Caro, M. L., Lombardi, G., Colao, A., and De Rosa, G. (2008). Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J. Endocrinol. Invest. 31, 216-223.
8. Fasanella, S., Leonardi, E., Cantaloni, C., and Eccher, C. (2011). Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn. Pathol. 6(Suppl. 1), S7.
9. Ferguson, M. K., Landreneau, R. J., Hazelrigg, S. R., Altorki, N. K., Naunheim, K. S., Zwischenberger, J. B., Kent, M., and Yim, A. P. (2000). Long-term outcome after resection for bronchial carcinoid tumors. Eur. J. Cardiothorac. Surg. 18, 156-161.
10. Fink, G., Krelbaum, T., Yellin, A., Bendayan, D., Saute, M., Glazer, M., and Kramer, M. R. (2001). Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119, 1647-1651.
11. García-Yuste, M., Matilla, J. M., Cueto, A., Paniagua, J. M., Ramos, G., Cañizares, M. A., Muguruza, I., and Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung for the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). (2007). Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur. J. Cardiothorac. Surg. 31, 192-197.
12. Gustafsson, B. I., Kidd, M., Chan, A., Malfertheiner, M. V., and Modlin, I. M. (2008). Bronchopulmonary neuroendocrine tumors. Cancer 113, 5-21.
13. Hage, R., de la Rivière, A. B., Seldenrijk, C. A., and van den Bosch, J. M. (2003). Update in pulmonary carcinoid tumors: a review article. Ann. Surg. Oncol. 10, 697-704.
14. Hurt, R., and Bates, M. (1984). Carcinoid tumours of the bronchus: a33yearexperience.Thorax 39, 617-623.
15. Kobayashi, Y., Tokuchi, Y., Hashimoto, T., Hayashi, M., Nishimura, H., Ishikawa, Y., Nakagawa, K., Sato, Y., Takahashi, A., and Tsuchiya, E. (2004). Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. Cancer Sci. 95, 334-341.
16. Laitinen, K. L., Soini, Y., Mattila, J., and Pääkkö, P. (2000). Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity. Cancer 88, 1590-1598.
17. Modlin, I. M., Lye, K. D., and Kidd, M. (2003). A 5-decade analysis of 13, 715 carcinoid tumors. Cancer 97, 934-959.
18. Paladugu, R. R., Benfield, J. R., Pak, H. Y., Ross, R. K., and Teplitz, R. L. (1985). Bronchopulmonary Kulchitsky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 55, 1303-1311.
19. Rugge, M., Fassan, M., Clemente, R., Rizzardi, G., Giacomelli, L., Pennelli, G., Mescoli, C., Segat, D., and Rea, F. (2008). Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin. Cancer Res. 14, 149-154.
20. Rusch, V. W., Klimstra, D. S., and Venkatraman, E. S. (1996). Molecular markers help characterize neuroendocrine lung tumors. Ann. Thorac. Surg. 62, 798-809; discussion 809-810.
21. Skov, B. G., Krasnik, M., Lantuejoul, S., Skov, T., and Brambilla, E. (2008). Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival. J. Thorac. Oncol. 3, 1410-1415.
22. Soga, J., and Yakuwa, Y. (1999). Bronchopulmonary carcinoids: an analysis of1, 875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann. Thorac. Cardiovasc. Surg. 5, 211-219.
23. Slodkowska, J., Langfort, R., Rudzinski, P., and Kupis, W. (1998). Typical and atypical pulmonary carcinoids - pathologic and clinical analysis of 77 cases. Pneumonol. Alergol. Pol. 66, 297-303.
24. Slodkowska, J., Markiewicz, T., and Grala, B. (2011). Accuracy of a remote quantitative image analysis in the whole slide images. Diagn. Pathol. 6(Suppl. 1), S20.
25. Travis, W. D., Giroux, D. J., Chansky, K., Crowley, J., Asamura, H., Brambilla, E., Jett, J., Kennedy, C., Rami-Porta, R., Rusch, V. W., Goldstraw, P., and International Staging Committee and Participating Institutions. (2008). The IASLC Lung Cancer Staging Project: proposals for the inclusion of bronchopulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J. Thorac. Oncol. 3, 1213-1223.
26. Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., and Koss, M. N. (1998a). Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am. J. Surg. Pathol. 22, 934-944.
27. Travis, W. D., Gal, A. A., Colby, T. V., Klimstra, D. S., Falk, R., and Koss, M. N. (1998b). Reproducibility of neuroendocrine lung tumor classification. Hum. Pathol. 29, 272-279.
28. Warren, W. H., and Hammar, S. P. (2006). The dispersed neuroendocrine system, its bronchopulmonary elements, and neuroendocrine tumors presumed to be derived from them: myths, mistaken notions, and misunderstandings. Semin. Thorac. Cardiovasc. Surg. 18, 178-182.